Novel Antibiotic Shows Success in Treatment of Plague and Melioidosis
Leading scientists at Defence Science and Technology Laboratory have made an exciting new discovery in the fight against some of ...
Tag: Burkholderia
U.S. Navy Researchers Collaborate with Australian Melioidosis Expert to Study Pathogen Risks to Servicemembers in Indo-Pacific
A team of researchers from Naval Medical Research Center (NMRC) are working to understand the risks associated with Burkholderia pseudomallei ...
2021 BAA for Development of Medical Countermeasures for Biological Threats
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), is soliciting research ...
Validated Methods for Removing Select Agent Samples from BSL-3 Labs
The Federal Select Agent Program dictates that all research entities in the United States must rigorously assess laboratory protocols to ...
Focus on Melioidosis: Highlighted News and Research
Melioidosis, also called Whitmore's disease, is an infectious disease that can infect humans or animals. The disease is caused by ...
Naval Research Laboratory Seeks to Advance Field Diagnostics of Infectious Agents
The Naval Research Laboratory (NRL) is seeking partners to advance technology developed for in vitro diagnostic devices that are amenable ...
Fundamental Research to Counter Biological, Chemical, and Nuclear Weapons
The Defense Threat Reduction Agency (DTRA) seeks to identify, adopt, and adapt emerging, existing and revolutionary sciences that may demonstrate ...
Navy Researchers Work to Reduce Risk of Melioidosis Among Deployed Military
Dr. Kevin Schully, contractor and chief science officer with Naval Medical Research Center’s (NMRC) Austere environments Consortium for Enhanced Sepsis ...
Melioidosis and the Role of Phages, UV Rays, and Fertilizer
An international research team has developed a mathematical model for monitoring and controlling the spread of melioidosis in Southeast Asia. ...
Collaboration Among BARDA, DTRA, USAMRIID and Spero to Advance SPR994
Spero Therapeutics, Inc. today announced that it was awarded funding of $15.7 million, with the potential for up to an additional $28.5 ...
BARDA BAA 2018: Pandemic Influenza, Infectious Diseases, CBRN Countermeasures
The Biomedical Advanced Research and Development Authority (BARDA) is soliciting proposals for the advanced research and development of medical countermeasures ...
Putting the Pieces Together: Solving the Burkholderia Puzzle
No definitive diagnostic test exists for Burkholderia, a category B agent caused by Burkholderia pseudomallei bacterium, which poses a threat ...
CUBRC, EpiVax Awarded DTRA Contract for Burkholderia Vaccine Antigen Design
CUBRC’s Biological and Medical Sciences team, in collaboration with EpiVax, Inc., has received a four-year grant worth $1.87 million from ...
Liposomal Ciprofloxacin as Broad-Spectrum Bioterrorism Countermeasures
The U.K. Defence Science and Technology Laboratory (Dstl) has received funding of up to $6.9 million from the U.S. Defense ...
GAO Recommendations on Select Agent Program Improvements
The total number of incidents involving incomplete inactivation—a process to destroy the hazardous effects of pathogens while retaining characteristics for ...
Northern Arizona University’s Burkholderia Diagnostics Program
Historically, Burkholderia assay development efforts have resulted in unreliable assays due, in large part, to the small genomic sample size upon ...
Soligenix Granted Fast Track Designation for Melioidosis Treatment
The US Food and Drug Administration (FDA) has awarded "Fast Track" designation to Soligenix, Inc. for development of SGX943 (dusquetide) ...
New Study Highlights Bigger Threat of Burkholderia
With the Deki Reader, researchers can test for a variety of diseases, such as malaria, dengue fever, melioidosis, and plague, ...
DoD CBRN Medical Countermeasure Consortium
Military program managers briefed biopharmaceutical industry and research organization representatives during a Nov. 2 Industry Day, part of an initiative ...
BAA – Medical Countermeasures for Priority Pathogens
The National Institute of Allergy and Infectious Diseases (NIAID) has released a new Broad Agency Announcement (BAA) to support development ...
